Mass spectroscopy based metabolomics
This metabolomics offers quantitative analysis with a high selectivity and sensitivity with a potential to identify the metabolites. Different ionization techniques are obtained to maximize the number of detected metabolites. Both (GC)-MS and (LC)-MS are superior for targeted analyses. In in-vivo studies , desorption electrospray ionization (DESI) may be a useful way to analyze tissue samples during surgery, MS is not used for in vivo metabolomics studies. The main chromatography techniques that are specifically coupled with MS are HPLC, gas chromatography, and capillary electrophoresis (CE). For example, investigations detailing a number of diseases including breast cancer, colorectal cancer, prostate cancer, esophageal and gastric cancer, cardiovascular diseases, kidney diseases , inborn errors of metabolism.
Related Conference of Mass spectroscopy based metabolomics
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Mass spectroscopy based metabolomics Conference Speakers
Recommended Sessions
- Analytical techniques
- Cancer metabolism
- Carbohydrates in metabolism
- Exometabolomics
- Immuno Metabolomics
- Lipids metabolism
- Mass spectroscopy based metabolomics
- Metabolic Fingerprinting
- Metabolic Pathways
- Metabolic Profiling
- Metabolic syndrome
- Metabolism
- Metabolism Syndrome Treatments
- Metabolites
- Metabolome
- Metabolomics
- Metabolomics Approaches
- Metabolomics in various Diseases
- Metabonomics
- Minerals and vitamins in metabolism
- NMR Spectroscopy Based Metabolomics
- Plant Metabolomics
- Proteins Metabolism
- Rare Metabolic Disorder
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)